746 articles in this topic
Scientists image NMDA receptors at atomic resolution, uncovering how calcium enters and magnesium blocks the channel underlying neuroplasticity.
New research links excess astrocytic cholesterol to impaired brain clearance — a potential key mechanism driving Alzheimer's progression.
Arginine supplements reduced toxic amyloid buildup, brain inflammation, and behavioral decline in fly and mouse Alzheimer's models.
A roundup of recent FDA brain-health approvals including lecanemab's full Alzheimer's approval and a new glioma drug.
Board-certified psychiatrist Dr. Paul Conti outlines practical frameworks for self-reflection, trauma healing, and overcoming self-destructive patterns.
fMRI study finds sport participation — not collision exposure — shapes neural processing in children's inhibitory control.
A memory clinic study finds 70% of patients tested positive for Alzheimer's pathology, with testing volumes exploding since new treatments arrived.
Combining polygenic and transcriptional risk scores from blood raises Alzheimer's detection accuracy, offering a less invasive screening path.
New research reveals dendrite branching is driven by random growth, with ligand contacts acting as brakes to sculpt precise neural architecture.
New research reveals microglia actively silence and reshape fear-encoding neurons during extinction learning, opening new PTSD treatment avenues.
A new NEJM case report highlights cerebral amyloid angiopathy, a vascular brain condition closely tied to cognitive decline and stroke risk.
A Cochrane review of 20,000+ patients finds amyloid-clearing drugs offer no meaningful benefit and raise brain bleed and swelling risks.
